Skip to main content

Peresolimab for RA: Phase 2a Results

Nov 16, 2022 8:00 am

Dr. Jonathan Kay abstract L03 at ACR22 Convergence in Philadelphia. L03: A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×